Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy

被引：0
|
作者：
Kanegae, Mizuki [1 ]
Kagawa, Naoki [1 ]
Kijima, Noriyuki [2 ]
Hirayama, Ryuichi [2 ]
Shimokado, Haruka [1 ,2 ]
Nishida, Sumiyuki [3 ]
Hosen, Naoki [4 ]
Tsuboi, Akihiro [5 ]
Oka, Yoshihiro [6 ]
Sugiyama, Haruo [7 ]
Kishima, Haruhiko [8 ]
Oji, Yusuke [1 ]
机构：
[1] Osaka Univ, CLBS, Grad Sch Med, Osaka, Japan
[2] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan
[3] Osaka Univ, Res Med Clin Imm, Grad Sch Med, Osaka, Japan
[4] Osaka Univ, Hematol Oncol, Grad Sch Med, Osaka, Japan
[5] Osaka Univ, Canc Immther, Grad Sch Med, Osaka, Japan
[6] Osaka Univ, Canc Stem Cell Biol, Grad Sch Med, Osaka, Japan
[7] Osaka Univ, Grad Sch Med, Osaka, Japan
[8] Osaka Univ, NeuroSurg, Grad Sch Med, Osaka, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12-2-6
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [31] Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures
    Meireson, Annabel
    Tavernier, Simon J.
    Van Gassen, Sofie
    Sundahl, Nora
    Demeyer, Annelies
    Spaas, Mathieu
    Kruse, Vibeke
    Ferdinande, Liesbeth
    Van Dorpe, Jo
    Hennart, Benjamin
    Allorge, Delphine
    Haerynck, Filomeen
    Decaestecker, Karel
    Rottey, Sylvie
    Saeys, Yvan
    Ost, Piet
    Brochez, Lieve
    CANCERS, 2021, 13 (11)
  • [32] WT1 Peptide Vaccine Is Able to Induce WT1-Specifc Immune Response with TCR Clonal Enrichment to Control Minimal Residual Disease in Patients with Myeloid Leukemia
    Liu, Hongtao
    Zha, Yuanyuan
    Malnassy, Gregory
    Fulton, Noreen
    Green, Margaret
    Park, Jae-Hyun
    Nakamura, Yusuke
    Larson, Richard A.
    Salazar, Andres M.
    Odenike, Olatoyosi
    Gajewski, Thomas
    Stock, Wendy
    BLOOD, 2016, 128 (22)
  • [33] Precisely Activating cGAS-STING Pathway with a Novel Peptide-Based Nanoagonist to Potentiate Immune Checkpoint Blockade Cancer Immunotherapy
    Xing, Yumeng
    Peng, Ao
    Yang, Jianhui
    Cheng, Zhifei
    Yue, Yi
    Liu, Feilong
    Li, Fenghe
    Liu, Yang
    Liu, Qi
    ADVANCED SCIENCE, 2024, 11 (15)
  • [34] Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
    Zhu, Shiyu
    Liang, Beibei
    Zhou, Yuxuan
    Chen, Yinfei
    Fu, Jiayu
    Qiu, Ling
    Lin, Jianguo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 625 - 640
  • [35] Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
    Shiyu Zhu
    Beibei Liang
    Yuxuan Zhou
    Yinfei Chen
    Jiayu Fu
    Ling Qiu
    Jianguo Lin
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 625 - 640
  • [36] Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma
    Sakai, Keiichi
    Shimodaira, Shigetaka
    Maejima, Shinya
    Udagawa, Nobuyuki
    Sano, Kenji
    Higuchi, Yumiko
    Koya, Terutsugu
    Ochiai, Takanaga
    Koide, Masanori
    Uehara, Shunsuke
    Nakamura, Midori
    Sugiyama, Haruo
    Yonemitsu, Yoshikazu
    Okamoto, Masato
    Hongo, Kazuhiro
    JOURNAL OF NEUROSURGERY, 2015, 123 (04) : 989 - 997
  • [37] DSP-7888, a Novel Cocktail Design of WT1 Peptide Vaccine, and Its Combinational Immunotherapy with Immune Checkpoint-Blocking Antibody Against PD-1
    Goto, Masashi
    Nakamura, Megumi
    Suginobe, Natsuko
    Takasu, Hideo
    Takanashi, Yosuke
    Ban, Hitoshi
    Li, Chiang J.
    BLOOD, 2016, 128 (22)
  • [38] Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM).
    Krug, L. M.
    Tsao, A. S.
    Kass, S.
    Rusch, V. W.
    Travis, W. D.
    Panageas, K.
    Adusumili, P. S.
    Kris, M. G.
    Maslak, P. G.
    Scheinberg, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Monitoring neuroinflammatory response to WT1 immunotherapy in glioma: 18F-DPA-714 and 11C-Methionine PET study with MR in mouse model.
    Ishibashi, Mana
    Watabe, Tadashi
    Kanai, Yasukazu
    Takano, Koji
    Nakajima, Hiroko
    Sugiyama, Haruo
    Shimosegawa, Eku
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [40] Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
    Kaida, Miho
    Morita-Hoshi, Yuriko
    Soeda, Atsuko
    Wakeda, Takako
    Yamaki, Yuni
    Kojima, Yasushi
    Ueno, Hideki
    Kondo, Shunsuke
    Morizane, Chigusa
    Ikeda, Masafumi
    Okusaka, Takuji
    Takaue, Yoichi
    Heike, Yuji
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (01) : 92 - 99
12345